Cargando…

Decreased Levels of Soluble Developmental Endothelial Locus-1 Are Associated with Thrombotic Microangiopathy in Pregnancy

HELLP (Hemolysis, Elevated Liver enzymes and Low Platelets) syndrome is a life-threatening complication of pregnancy, which is often secondary to preeclampsia. To date, there is no biomarker in clinical use for the early stratification of women with preeclampsia who are under increased risk of HELLP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romanidou, Gioulia, Konstantinidis, Theocharis G., Natsi, Anastasia-Maria, Kantartzi, Konstantia, Panopoulou, Maria, Kontomanolis, Emmanouil, Tsigalou, Christina, Lambropoulou, Maria, Gavriilaki, Eleni, Panagoutsos, Stylianos, Pasadakis, Ploumis, Mitroulis, Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380227/ https://www.ncbi.nlm.nih.gov/pubmed/37511523 http://dx.doi.org/10.3390/ijms241411762

Ejemplares similares

Study of Antiphospholipid Antibodies in Patients with Arterial Hypertension
por: Romanidou, Gioulia, et al.
Publicado: (2018)

Focus on the Gut–Kidney Axis in Health and Disease
por: Stavropoulou, Elisavet, et al.
Publicado: (2021)

Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2
por: Konstantinidis, Theocharis G., et al.
Publicado: (2021)

An Update in Drug-Induced Thrombotic Microangiopathy
por: Chatzikonstantinou, Thomas, et al.
Publicado: (2020)

Hepatitis E Virus (HEV) Infection in Hemodialysis Patients: A Multicenter Epidemiological Cohort Study in North-Eastern Greece
por: Kogias, Dionysios, et al.
Publicado: (2023)

Unraveling the Interconnection Patterns Across Lung Microbiome, Respiratory Diseases, and COVID-19
por: Stavropoulou, Elisavet, et al.
Publicado: (2021)

Microbiome, Immunosenescence, and Chronic Kidney Disease
por: Stavropoulou, Elisavet, et al.
Publicado: (2021)

The Association of dp-ucMGP with Cardiovascular Morbidity and Decreased Renal Function in Diabetic Chronic Kidney Disease
por: Roumeliotis, Stefanos, et al.
Publicado: (2020)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
por: Gavriilaki, Eleni, et al.
Publicado: (2019)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021)

Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura
por: Ban, Byung H., et al.
Publicado: (2017)

Intradialytic Cardiovascular Exercise Training Alters Redox Status, Reduces Inflammation and Improves Physical Performance in Patients with Chronic Kidney Disease
por: Sovatzidis, Apostolos, et al.
Publicado: (2020)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Dialysis Patients Respond Adequately to Influenza Vaccination Irrespective of Dialysis Modality and Chronic Inflammation
por: Pleros, Christos, et al.
Publicado: (2023)

Legionella pneumophila: The Journey from the Environment to the Blood
por: Iliadi, Valeria, et al.
Publicado: (2022)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Thrombotic microangiopathy in renal allografts
por: Radha, S., et al.
Publicado: (2014)

Influenza-associated thrombotic microangiopathies
por: Bitzan, Martin, et al.
Publicado: (2017)

Acyclovir-induced thrombotic microangiopathy
por: Goli, R., et al.
Publicado: (2017)

Cancer-associated thrombotic microangiopathy
por: Govind Babu, K, et al.
Publicado: (2016)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

COVID-19 and thrombotic microangiopathies
por: Tiwari, Nishant R., et al.
Publicado: (2021)

Thrombotic microangiopathies: An illustrated review
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2022)

Diagnosis and treatment of thrombotic microangiopathy
por: Thompson, Gemma L., et al.
Publicado: (2022)

Chemotherapy-Associated Thrombotic Microangiopathy
por: Aklilu, Abinet M., et al.
Publicado: (2023)

Thrombotic microangiopathy associated with use of interferon-beta
por: Olea, Teresa, et al.
Publicado: (2012)

Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Thrombotic microangiopathy in a patient with COVID-19
por: Jhaveri, Kenar D., et al.
Publicado: (2020)

Renal Thrombotic Microangiopathy in Concurrent COVID-19 Vaccination and Infection
por: De Fabritiis, Marco, et al.
Publicado: (2021)

Thrombotic microangiopathy and associated renal disorders*
por: Barbour, Thomas, et al.
Publicado: (2012)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Thrombotic microangiopathy associated with proteasome inhibitors
por: Lodhi, Ahad, et al.
Publicado: (2015)

Cabozantinib‐induced renal thrombotic microangiopathy
por: La Manna, Gaetano, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_caco0u87ege63m9lpbm4msthr6